Allied Market Research

Non-Hodgkin Lymphoma Therapeutics Market - Global Opportunity Analysis and Industry Forecast, 2017 – 2023

Non-Hodgkin Lymphoma Therapeutics Market Size is Set to Grow at a Remarkable Pace in the Coming Years.

 

Portland, OR -- (SBWIRE) -- 09/26/2017 -- Non-Hodgkin lymphoma (NHL) is a condition where abnormal lymphocytes are produced in the human body. These lymphocytes do not die and keep growing and dividing within the body unless treated. NHL is generally located at lymph nodes, however, if not treated in time then it might spread to the entire lymphatic system.

Factors such as demand for innovative drugs and novel technologies, FDA's approval for chronic lymphocytic leukemia therapy drugs, introduction of promising drugs such as novel small molecule inhibitors and next-generation monoclonal antibodies, and increase in prevalence of NHL drives the market growth. However, high cost of the vaccines used in NHL therapy and side-effects associated with them restrain the market growth. Moreover, introduction of newer biologics in the NHL market, patent expiry of standard drugs in untapped market provide numerous opportunities regarding healthcare in near future.

Request TOC and Sample Report:
https://www.alliedmarketresearch.com/request-toc-and-sample/4229

The key players in the market include Bristol Myers Squibb Co., Celgene Corp., Eli Lilly and Co., F. Hoffman La-Roche Ltd., GlaxoSmithKline plc, Accredo Health Group Inc., Baxter International Inc., Bayer AG, Cephalon Inc., and Eisai Pharmaceuticals Inc.

Global Non-hodgkin Lymphoma Therapeutics Market Key Segments:
By Type of Therapy
- Chemotherapy
- Targeted Therapy

By Cell type
- B-Cell Lymphomas
- T-Cell Lymphoma

By Region
- North America
o U.S.
o Canada
o Mexico

- Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe

- Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific

- LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA

Access full summary at:
https://www.alliedmarketresearch.com/non-hodgkin-lymphoma-therapeutics-market

About Allied Market Research
Allied Market Research is a Market Research Company which offers Syndicate & Custom Market Research Reports with Consulting Services.

Contact Us:
5933 NE Win Sivers Drive,
#205, Portland, OR 97220,
United States.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com